NanoViricides Inc. (NNVC)

[drkazmd65]

I don't think anything is quite that simple MJJ - nothing ever is:

Option one is, the stock goes belly up. In order for that to happen the science behind NNVC will need to either have been a scam from the get go or just simply been a statistic and failed in human testing, in other words, they tried but couldn't pull it off. If that were the case, thousands of people would lose their money, dozens out of work and millions of people would still have to suffer with illness and or die. But, a few people who spend their lives shorting and attacking stocks such as this, make a few pennies!

Option two is, the company succeeds(I won't bother going into the obvious details of this option) and those same thousands of people who are invested under the belief in success, make millions, heck, billions of dollars. The ripple effect of those billions creates business, jobs, cash flow, taxes that go toward the common good, you know, things like that! Most importantly, millions of lives are saved, countless amounts of people no longer need to suffer with disease (viral at least). The financial ripple effect of that is exponentially greater than the benefits noted above.

While I (obviously) am wagering that Option 2 is the far more likely outcome - some variation of Option 1 remains a (low IMO) probability.

I'm honest enough to admit that possibility - although - as I stated - I don't view it as the likely outcome.

Most of the things that could have gone horribly wrong that could have completely derailed NNVC/TheraCour to make the company go belly up have been eliminated as significant factors.

With the new (and paid for) GLP/GMP-ready plant at Shelton - with sufficient power, water, space and with the needed "clean" lab space and trained staff,.... making the materials needed to do TOX and Clinical testing is no longer a "Can they ever do it" question and is now a "When will they get it done" question. Scale-up to 500 g from 200 g with about 6-7 months' working on the problem consistently tells us that the next step up is a question of time,.... and concentration on the problem.

With considerably more than $26 MM in the bank and a burn rate of a couple of million dollars a quarter - the company is not in imminent danger of going bankrupt - or of needing to raise more money via dilutive stock or security sales.

With the topical/optical HerpeCide option - and the lower needs for huge quantities of compound to complete TOX testing - the critical short-term need (though it remains a long-term need) to achieve >Kg scales of synthesis is mitigated. Shortening the path to get a compound into clinical testing (and the long-delayed FluCide TOX completion) is also a factor that lowers risk for potential investors.

There are (obviously) many other positive factors that I know I see here for NNVC,... and the fact that many others disagree is irrelevant except for the fact that temporarily lower share prices give me the opportunity (should I be so inclined) to add to my stash of shares at what I consider a good long-term pricetag.

The reality of what we shall see here for NNVC (IMO of course) is closer to Option 2. I personally don't think (but hope to be wrong) that we'll see an 'explosion!' in share prices for NNVC to 'hundreds of dollars' per share until or unless FluCide is a success, and until the company's production capacity (via expansion into a new plant or some licensed big-Pharma taking the ball & running with it) starts generating big-time revenue.

A successful HerpeCide will bring in revenue (of course) - but I'm thinking that the result will be in the tens of dollars/share from just that success,.... not the hundreds.